Italfarmaco Sa Drug Patent Portfolio
Italfarmaco Sa owns 1 orange book drug protected by 1 US patent Given below is the list of Italfarmaco Sa's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US8765150 | Riluzole aqueous suspensions | 12 Mar, 2029 | Active |
Latest Legal Activities on Italfarmaco Sa's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Italfarmaco Sa.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Payment of Maintenance Fee, 8th Year, Large Entity | 03 Jan, 2022 | US8765150 |
| Payment of Maintenance Fee, 4th Year, Large Entity | 02 Jan, 2018 | US8765150 |
|
Patent Issue Date Used in PTA Calculation
Critical
| 01 Jul, 2014 | US8765150 |
|
Recordation of Patent Grant Mailed
Critical
| 01 Jul, 2014 | US8765150 |
|
Email Notification
Critical
| 12 Jun, 2014 | US8765150 |
|
Issue Notification Mailed
Critical
| 11 Jun, 2014 | US8765150 |
| Dispatch to FDC | 29 May, 2014 | US8765150 |
| Printer Rush- No mailing | 27 May, 2014 | US8765150 |
| Mail Miscellaneous Communication to Applicant | 27 May, 2014 | US8765150 |
|
Email Notification
Critical
| 27 May, 2014 | US8765150 |
|
Application Is Considered Ready for Issue
Critical
| 22 May, 2014 | US8765150 |
| Miscellaneous Communication to Applicant - No Action Count | 20 May, 2014 | US8765150 |
|
Pubs Case Remand to TC
Critical
| 16 May, 2014 | US8765150 |
|
Issue Fee Payment Received
Critical
| 15 May, 2014 | US8765150 |
|
Issue Fee Payment Verified
Critical
| 15 May, 2014 | US8765150 |
Italfarmaco Sa's Family Patents
Italfarmaco Sa drugs have patent protection in a total of 21 countries. It's US patent count contributes only to 4.3% of its total global patent coverage. 4 countries have all of their patents expired or invalidated which has opened up potential generic launch opportunities in these countries. Click
below to unlock the full patent family tree.
Italfarmaco Sa Drug List
Given below is the complete list of Italfarmaco Sa's drugs and the patents protecting them.
1. Tiglutik Kit
Tiglutik Kit is protected by 1 patent, which is still active. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US8765150 | Riluzole aqueous suspensions |
12 Mar, 2029
(4 years from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Tiglutik Kit's drug page
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List